Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China

BACKGROUND: Inetetamab (cipterbin) is an innovative anti-HER2 humanized monoclonal antibody. The efficacy and safety of a combination of inetetamab and vinorelbine in the first-line treatment of human epidermal receptor positive (HER2+) metastatic breast cancer (MBC) have been confirmed. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoyu, Zhang, Peng, Li, Chao, Song, Xiang, Liu, Zhaoyun, Shao, Wenna, Li, Sumei, Wang, Xinzhao, Yu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316697/
https://www.ncbi.nlm.nih.gov/pubmed/37404769
http://dx.doi.org/10.3389/fonc.2023.1136380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316697/
https://www.ncbi.nlm.nih.gov/pubmed/37404769
http://dx.doi.org/10.3389/fonc.2023.1136380

Ejemplares similares